Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rare Disease & Oncology Consulting is a private healthcare and biopharma consulting company focused on strategic and clinical-development advisory work in rare diseases and oncology. The business appears to be centered around the expertise of physician-executive May Orfali, who has been identified as owner and principal consultant. Publicly available information suggests the firm provides consulting services rather than developing its own therapeutic pipeline, with work spanning clinical development, medical affairs, and related strategic support for life sciences companies. It is based in Beverly/Beverly Farms, Massachusetts and appears to be an active LLC rather than a drug developer or sponsor with proprietary assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rare Disease & Oncology Consulting.